FNA Tumor Sampling for CD137 Modulation: A Pilot Study

Trial ID or NCT#

NCT01114256

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to better understand the biology of the body's immune response to monoclonal antibody therapy for cancer. Your health information will be used to identify your tissues. The tissue we obtain may be useful for research or education, resulting in new drugs, therapies or diagnostic procedures.

Official Title

FNA Tumor Sampling for CD137 Modulation: A Pilot Study

Eligibility Criteria

Ages Eligible for Study: Older than 21 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

A. Dimitrios Colevas, MD
A. Dimitrios Colevas, MD
Medical oncologist, Head and neck specialist, Cutaneous oncology specialist
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
Christina Kong
Christina Kong
Pathologist, Cytopathologist, Surgical pathologist
Professor of Pathology

Contact us to find out if this trial is right for you.

Contact

Risa Jiron
650-736-1598